Heavyweights
Sales of blockbuster GLP-1s are expected to grow in 2026, albeit at a slower pace, despite the introduction of new oral options.
.png){kind=small}
Sales of blockbuster GLP-1s are expected to grow in 2026, albeit at a slower pace, despite the introduction of new oral options.